In CKD patients not yet on dialysis (S1 Table), male gender, history of CVD, higher age, phosphate, FGF23, PTH (both assays), and lower eGFR, bicarbonate, calcitriol, blood platelets all were significantly associated with higher serum sclerostin levels. Here, FGF23 is linked to chronic kidney disease.